Literature DB >> 7419900

Estrogen receptor cytochemistry by fluorescent estrogen.

I Nenci, W B Dandliker, C Y Meyers, E Marchetti, A Marzola, G Fabris.   

Abstract

A recently synthesized fluorescein-labeled estrogen (17FE, 1-(N)-fluoresceinyl-estrone-thiosemicarbazone) interacts with estrogen-target cells like the native hormone and visualizes the uptake, transport, and distribution of estrogen in intact target cells. Moreover, estrogen binding sites are traced by 17FE in cryostat sections of estrogen target tissues as well. Cell and tissue 17FE binding sites fulfill the accepted criteria for specific estrogen receptors (finite binding capacity, high affinity, steroid and tissue specificity). This fluorescent probe allows estrogen receptors to be studied in a wide variety of cell and tissue preparations under varying conditions of physiologic and pathophysiologic interest.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7419900     DOI: 10.1177/28.10.7419900

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  8 in total

1.  Cytochemistry of sex steroid receptors: a critique.

Authors:  K S McCarty; D S Reintgen; H F Seigler; K S McCarty
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

2.  Rapid and sensitive detection of oestrogen receptors in cells and tissue sections by autoradiography with 125I-oestradiol.

Authors:  E M Berns; F F Rommerts; E Mulder
Journal:  Histochem J       Date:  1985-11

3.  The histochemistry of estrogen receptors.

Authors:  S H Lee
Journal:  Histochemistry       Date:  1981

4.  Sensitive three-parameter flow-cytometric detection of abnormal cells in human cervical cancers: a pilot study.

Authors:  G Valet; M G Ormerod; H H Warnecke; G Benker; G Ruhenstroth-Bauer
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

5.  Fluorescent ligands, used in histocytochemistry, do not discriminate between estrogen receptor-positive and receptor-negative human tumor cell lines.

Authors:  E M Berns; E Mulder; F F Rommerts; R A Blankenstein; E de Graaf; H J van der Molen
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

6.  Ultrastructural evidence for endogenous testosterone immunoreactivity in the pituitary gland of the rat.

Authors:  G Morel; M G Forest; P M Dubois
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

7.  Immunohistologic and histochemical methods for detection of steroid binding in breast cancer: a reappraisal.

Authors:  L P Pertschuk; E H Tobin; A C Carter; K B Eisenberg; V C Leo; E Gaetjens; N D Bloom
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

8.  Synthesis and pharmacological characterization of fluorescent opioid receptor probes.

Authors:  V M Kolb; A D Koman; A Neil
Journal:  Pharm Res       Date:  1985-11       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.